Clinical trial
Evaluation of the Feasibility, Accuracy, and Effect of a Rapid Point-of-Care Serological Triage Test for Active TB (SeroSelectTB) in High Burden, HIV-endemic African Settings: a Multi-centre, Parallel-group, Randomised, Controlled Trial
NCT04752592 is registered in ClinicalTrials.gov with Norwegian Institute of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Feasibility, Accuracy, and Effect of a Rapid Point-of-Care Serological Triage Test for Active TB (SeroSelectTB) in High Burden, HIV-endemic African Settings: a Multi-centre, Parallel-group, Randomised, Controlled Trial
- Lead sponsor
- Norwegian Institute of Public Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 21, 2021
- Completion date
- December 31, 2025
- Enrollment
- 9,097 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.